Cargando…
Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity
Although human liver tumor cells have reduced metabolic functions as compared to primary human hepatocytes (PHH) they are widely used for pre-screening tests of drug metabolism and toxicity. The aim of the present study was to modify liver cancer cell lines in order to improve their drug-metabolizin...
Autores principales: | Ruoß, Marc, Damm, Georg, Vosough, Massoud, Ehret, Lisa, Grom-Baumgarten, Carl, Petkov, Martin, Naddalin, Silvio, Ladurner, Ruth, Seehofer, Daniel, Nussler, Andreas, Sajadian, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358789/ https://www.ncbi.nlm.nih.gov/pubmed/30654452 http://dx.doi.org/10.3390/ijms20020347 |
Ejemplares similares
-
Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7
por: Sajadian, Sahar Olsadat, et al.
Publicado: (2016) -
Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells
por: Franko, Andras, et al.
Publicado: (2019) -
Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma
por: Schicht, Gerda, et al.
Publicado: (2022) -
Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
por: Sajadian, Sahar Olsadat, et al.
Publicado: (2015) -
Development of Scaffolds with Adjusted Stiffness for Mimicking Disease-Related Alterations of Liver Rigidity
por: Ruoß, Marc, et al.
Publicado: (2020)